HR Execs on the Move

Baebies

www.baebies.com

 
Baebies are guided by a vision that every newborn deserves a healthy start, irrespective of the socio-economic status and geographic location. They are on a mission to save lives and make lives better for millions of babies by bringing new technologies, new tests, and new hope to parents and healthcare professionals worldwide.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.baebies.com
  • 615 Davis Drive Suite 800
    Durham, NC USA 27560
  • Phone: 844.244.4034

Executives

Name Title Contact Details
Vijay Srinivasan
Vice President of Product Development Profile
Richard West
Chief Executive Officer Profile

Similar Companies

Davis Medical Electronics Inc

Davis Medical Electronics Inc is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cyrano Therapeutics

The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.

VentureMed Group

VentureMed Group, Inc. is a commercial-stage medical device company that develops and markets cost-effective interventional devices to improve the treatment of peripheral artery disease.

Kinetic Instruments

Kinetic Instruments is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Analogic

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.